原发性骨肉瘤患者中不确定性肺结节的临床意义:一项系统综述
该系统综述纳入6项研究共1667例原发性骨肉瘤患者,汇总分析发现不确定性肺结节(IPN)发生率为18.1%(302/1667),进展为转移率为45.0%(136/302)。结节直径大于5 mm、数量≥4个、双侧分布、不完全钙化及分叶边缘与IPN进展为转移的可能性增加相关,但其对总生存或无事件生存的影响尚不明确。作者建议对这类患者的IPN至少随访2年,于3、6、12个月间隔行CT成像,尤其是平均直径>5 mm的结节。
要点
- 原发性骨肉瘤患者IPN发生率为18.1%,其中45.0%进展为转移。
- 结节>5 mm、≥4个、双侧分布、不完全钙化及分叶边缘与进展为转移可能性增加相关。
- 作者建议IPN至少随访2年,于3、6、12个月间隔行CT成像,尤其针对平均直径>5 mm的结节。
核心结论
- 原发性骨肉瘤患者IPN进展为转移的风险不可忽视,大的IPN有高风险为实际转移;作者建议对这类患者的IPN至少随访2年,于3、6、12个月间隔行CT成像,尤其是平均直径>5 mm的结节。
研究设计与样本
- 系统综述,检索Medline、Embase和Cochrane Library从建库至2023年发表的英文文献,纳入6项研究共1667例原发性骨肉瘤患者,采用纽卡斯尔-渥太华队列研究质量评估表评价偏倚风险。
关键影像表现/征象
- 结节大小(直径大于5 mm)、数量(大于或等于4个)、分布(双侧分布)、不完全钙化及分叶边缘与IPN进展为转移的可能性增加相关。
- 上述影像参数对总生存或无事件生存的影响尚不明确。
诊断标准与关键数值
- IPN发生率为18.1%(302/1667)。
- IPN进展为转移率为45.0%(136/302)。
临床应用与阅片要点
- 作者建议对原发性骨肉瘤患者的IPN至少随访2年,于3、6、12个月间隔行CT成像。
- 作者建议尤其关注平均直径>5 mm的结节。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To report the incidence of indeterminate pulmonary nodules (IPN) and the rate of progression of IPNs to metastasis in patients with primary bone cancers. We also aimed to evaluate clinical or radiological parameters that may identify IPNs more likely to progress to metastatic disease and their effect on overall or event-free survival in patients with primary bone sarcoma.
METHODS: A systematic search of the electronic databases Medline, Embase, and Cochrane Library was undertaken for eligible articles on IPNs in patients with primary bone sarcomas, published in the English language from inception of the databases to 2023. The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was utilized to evaluate risk of bias in included studies.
RESULTS: Six studies, involving 1667 patients, were included in this systematic review. Pooled quantitative analysis found the rate of incidence of IPN to be 18.1% (302 out of 1667) and the rate of progression to metastasis to be 45.0% (136 out of 302). Nodule size (more than 5 mm diameter), number (more than or equal to 4), distribution (bilaterally distributed), incomplete calcification, and lobulated margins were associated with an increased likelihood of IPNs progressing to metastasis, however, their impact on overall or event-free survival remains unclear.
CONCLUSION: The risk of IPNs progressing to metastasis in patients with primary bone sarcoma is non-negligible. Large IPNs have a high risk to be an actual metastasis. We suggest that IPNs in these patients be followed up for a minimum of 2 years with CT imaging at 3, 6, and 12 month intervals, particularly for nodules measuring >5 mm in average diameter.
ADVANCES IN KNOWLEDGE: This is the first systematic review on IPNs in patients with primary bone sarcomas only and proposes viable management strategies for such patients.
引用
- Hassan MS, Ariyaratne S, Azzopardi C, et al. The clinical significance of indeterminate pulmonary nodules in patients with primary bone sarcoma: a systematic review. Br J Radiol. 2024. PMID: 38346703. doi:10.1093/bjr/tqae040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。